|
Q2 2019
Filed on Aug 14, 2019
|
300
|
$97.79 - $107.67
$29.3K - $32.3K
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
9,000
|
$4.03 - $5.1
$36.3K - $45.9K
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
90
|
$279.29 - $336.89
$25.1K - $30.3K
|
|
Biomarin Pharmaceutical Inc
|
Q2 2019
Filed on Aug 14, 2019
|
226,000
|
N/A
|
|
Osiris Therapeutics Inc New
|
Q2 2019
Filed on Aug 14, 2019
|
29,992
|
N/A
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
0
|
N/A
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
4,000
|
N/A
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
0
|
N/A
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
305,000
|
N/A
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
0
|
N/A
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
1,310
|
$29.71 - $35.27
$38.9K - $46.2K
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
0
|
N/A
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
0
|
$3.17 - $3.58
$0 - $0
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
0
|
N/A
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
500,000
|
N/A
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
4,000
|
$6.99 - $11.27
$28K - $45.1K
|
|
Berkshire Hathaway Inc Del
|
Q2 2019
Filed on Aug 14, 2019
|
3,000
|
N/A
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
5,000
|
N/A
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
2,000
|
N/A
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
2,500
|
N/A
|
|
Huntington Ingalls Inds Inc
|
Q2 2019
Filed on Aug 14, 2019
|
0
|
N/A
|
|
Invesco Curncyshs Japanese Y
|
Q2 2019
Filed on Aug 14, 2019
|
0
|
N/A
|
|
Invesco Currencyshares Euro
|
Q2 2019
Filed on Aug 14, 2019
|
0
|
N/A
|
|
United States Oil Fund LP
|
Q2 2019
Filed on Aug 14, 2019
|
1,000
|
N/A
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
0
|
N/A
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
0
|
N/A
|
|
Teva Pharmaceutical Inds LTD
|
Q2 2019
Filed on Aug 14, 2019
|
0
|
N/A
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
4,200
|
N/A
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
0
|
N/A
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
7,000
|
N/A
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
0
|
N/A
|
|
|
Q2 2019
Filed on Aug 14, 2019
|
0
|
N/A
|
|
Washington Prime Group New
|
Q1 2019
Filed on May 13, 2019
|
600
|
N/A
|
|
|
Q1 2019
Filed on May 13, 2019
|
4,100
|
N/A
|
|
Bellicum Pharmaceuticals Inc
|
Q1 2019
Filed on May 13, 2019
|
1,500
|
N/A
|
|
|
Q1 2019
Filed on May 13, 2019
|
1,040,000
|
N/A
|
|
|
Q1 2019
Filed on May 13, 2019
|
246
|
$103.43 - $106.84
$25.4K - $26.3K
|
|
|
Q1 2019
Filed on May 13, 2019
|
17,400
|
N/A
|
|
|
Q1 2019
Filed on May 13, 2019
|
4,000
|
N/A
|
|
|
Q1 2019
Filed on May 13, 2019
|
4,600
|
N/A
|
|
|
Q1 2019
Filed on May 13, 2019
|
390,000
|
N/A
|
|
|
Q1 2019
Filed on May 13, 2019
|
9
|
N/A
|
|
|
Q1 2019
Filed on May 13, 2019
|
2,300,000
|
N/A
|
|
|
Q1 2019
Filed on May 13, 2019
|
3,000
|
$9.6 - $15.96
$28.8K - $47.9K
|
|
|
Q1 2019
Filed on May 13, 2019
|
17,200
|
$11.63 - $14.61
$200K - $251K
|
|
|
Q1 2019
Filed on May 13, 2019
|
525
|
N/A
|
|
|
Q1 2019
Filed on May 13, 2019
|
502
|
$121.89 - $167.19
$61.2K - $83.9K
|
|
|
Q1 2019
Filed on May 13, 2019
|
1,500,000
|
N/A
|
|
|
Q1 2019
Filed on May 13, 2019
|
3,439,000
|
N/A
|
|
|
Q1 2019
Filed on May 13, 2019
|
17,047
|
$11.01 - $12.23
$188K - $208K
|
|